1 – 5 of 12
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
(
- Contribution to journal › Article
- 2013
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
(
- Contribution to journal › Article
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
(
- Contribution to journal › Article